Detalles de la búsqueda
1.
Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).
Int J Clin Oncol
; 28(1): 79-88, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36414827
2.
Phase I/II Study of Cisplatin plus Nab-Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer.
Oncologist
; 26(1): 19-e52, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918791
3.
Cardiovascular Complications Associated with Contemporary Lung Cancer Treatments.
Curr Treat Options Oncol
; 22(8): 71, 2021 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34110522
4.
Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial.
Lancet Oncol
; 21(6): 843-850, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32502444
5.
Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.
Jpn J Clin Oncol
; 48(4): 367-375, 2018 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29474558
6.
Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors.
Invest New Drugs
; 33(2): 380-8, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25502863
7.
A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.
Invest New Drugs
; 33(5): 1058-67, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26259955
8.
Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: phase i study in Japanese patients with advanced solid malignancies and advanced breast cancer.
Invest New Drugs
; 32(5): 946-54, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24875132
9.
Cancer awareness and its related factors among junior high and high school teachers in Japan: a cross-sectional survey.
Arch Public Health
; 82(1): 71, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745251
10.
Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial.
Lung Cancer
; 191: 107557, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38626709
11.
Severe Drug-Induced Interstitial Lung Disease After Administration of Osimertinib as Adjuvant Treatment for Resected EGFR-Mutated NSCLC: A Case Report.
JTO Clin Res Rep
; 5(2): 100631, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38322711
12.
Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials.
Cancer Sci
; 104(4): 481-5, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23331490
13.
Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor.
Cancer Sci
; 104(1): 98-104, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23020774
14.
First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumours.
Invest New Drugs
; 31(1): 108-14, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22415795
15.
Details of Cancer Education Programs for Adolescents and Young Adults and Their Effectiveness: A Scoping Review.
J Adolesc Young Adult Oncol
; 12(1): 9-33, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35180351
16.
The cytotoxicity of gefitinib on patientderived induced pluripotent stem cells reflects gefitinibinduced liver injury in the clinical setting.
Oncol Lett
; 26(6): 520, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37927418
17.
Tumor Microenvironment Landscape of NSCLC Reveals Resistance Mechanisms for Programmed Death-Ligand 1 Blockade After Chemoradiotherapy: A Multicenter Prospective Biomarker Study (WJOG11518L:SUBMARINE).
J Thorac Oncol
; 18(10): 1334-1350, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37364849
18.
Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure.
Biochem Biophys Res Commun
; 407(1): 219-24, 2011 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21377448
19.
Comparison Between Second- and Third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as First-line Treatment in Patients With Non-small-cell Lung Cancer: A Retrospective Analysis.
Anticancer Res
; 41(10): 5137-5145, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34593465
20.
A Phase 1 clinical study of temsirolimus (CCI-779) in Japanese patients with advanced solid tumors.
Jpn J Clin Oncol
; 40(8): 732-8, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20430774